Valuation: GKB Ophthalmics Limited

Market Cap 321M 3.35M 2.89M 2.72M 2.47M 4.65M 4.72M 31.93M 12.51M 161M 12.58M 12.3M 535M P/E 2025
-4.32x
P/E 2026 21.7x
Enterprise Value 393M 4.11M 3.55M 3.34M 3.03M 5.7M 5.79M 39.14M 15.34M 197M 15.41M 15.08M 655M EV / Sales 2025
0.29x
EV / Sales 2026 0.23x
Free-Float
21.95%
Yield 2025 *
-
Yield 2026 -
08-12 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
05-27 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-08-14 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-05-30 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
25-02-13 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
24-11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-08-13 GKB Ophthalmics Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
24-05-30 GKB Ophthalmics Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
24-03-19 GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director CI
24-02-14 GKB Ophthalmics Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
23-11-14 GKB Ophthalmics Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
1 day-4.21%
1 week-0.70%
Current month+5.17%
1 month+2.59%
3 months-6.18%
6 months+1.67%
Current year+19.05%
1 week 60
Extreme 60
69.95
1 month 55
Extreme 55
69.95
Current year 48.15
Extreme 48.15
76.9
1 year 45.25
Extreme 45.25
91.7
3 years 45.25
Extreme 45.25
136.4
5 years 45.25
Extreme 45.25
197.9
10 years 28.35
Extreme 28.35
209.2
Manager TitleAgeSince
Chief Executive Officer 84 1981-12-09
Director of Finance/CFO - 2019-03-31
Chief Administrative Officer 62 2024-05-31
Director TitleAgeSince
Chairman 84 1981-12-09
Director/Board Member 57 1996-07-23
Director/Board Member 68 2023-06-19
Change 5-day change 1-year change 3-year change Capi.($)
-4.21%-0.70%-25.65%-32.00% 3.35M
+2.57%-4.57%-38.80%-5.53% 87.21B
+2.48%-1.18%-15.63%-16.50% 35.89B
+0.88%-1.38%+3.03%-17.87% 14.78B
+0.57%+7.76% - - 11.4B
-2.02%+6.52%-5.37%+703.23% 2.51B
-1.92%-4.50%-41.45%-58.30% 1.49B
-3.95%-3.56%+50.76%-7.45% 918M
+0.44%-0.93%-38.99%-20.28% 883M
-0.55%-4.37%+13.86%+6.32% 869M
Average -0.57%+0.54%-10.92%+61.29% 15.6B
Weighted average by Cap. +2.06%-2.11%-27.33%+2.21%

Financials

2025 2026
Net sales 1.09B 11.37M 9.82M 9.24M 8.4M 15.8M 16.03M 108M 42.49M 545M 42.71M 41.78M 1.82B 1.49B 15.56M 13.44M 12.64M 11.49M 21.61M 21.93M 148M 58.12M 746M 58.41M 57.14M 2.48B
Net income -70.45M -735K -635K -597K -543K -1.02M -1.04M -7.01M -2.75M -35.23M -2.76M -2.7M -117M 12.18M 127K 110K 103K 93.93K 177K 179K 1.21M 475K 6.09M 477K 467K 20.3M
Net Debt 15.59M 163K 141K 132K 120K 226K 229K 1.55M 608K 7.8M 611K 598K 25.97M 72.38M 755K 652K 614K 558K 1.05M 1.06M 7.2M 2.82M 36.2M 2.84M 2.77M 121M
Logo GKB Ophthalmics Limited
GKB Ophthalmics Limited is engaged in manufacturing and sale of unfinished ophthalmic lenses. The Company is also focused on the business of manufacturing and supply of semi-finished plastic lenses. The Company operates through the Ophthalmics Lenses segment. Its products consist of organic semifinished lenses, which include single vision, bifocal, progressive and aspheric lenses. The single vision lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 CLEAR, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE, 1.50 Q-SHADE+ and 1.50 SUNSENSOR. Its bifocal lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 BLUCHECK, 1.56 DAYNITE, 1.56 DAYNITE FAST CHANGE and 1.50 Q-SHADE+. Its progressive lenses include 1.498 CR-39, 1.50 BLUCHECK, 1.56 DAYNITE and 1.56 DAYNITE FAST CHANGE. Its aspheric lens includes 1.498 CR-39. The Company’s products are exported to various countries across the globe. Its subsidiaries include GSV Ophthatmics Private Limited, GKB Ophthalmics Products FZE, and others.
Employees
156
Date Price Change Volume
26-08-19 61.00 -4.21% 785
26-08-18 ₹63.68 -2.03% 274
26-08-17 ₹65.00 0.00% 2,236
26-08-14 ₹65.00 +0.02% 18,890
26-08-13 ₹64.99 +5.80% 5,318